• OPEN AN ACCOUNT
Indian Indices
Nifty
24,346.70 12.50
(0.05%)
Sensex
80,501.99 259.75
( 0.32%)
Bank Nifty
55,115.35 28.20
( 0.05%)
Nifty IT
35,891.85 96.90
( 0.27%)
Global Indices
Nasdaq
40,753.42 63.06
(0.15%)
Dow Jones
5,622.11 32.05
(0.57%)
Hang Seng
36,831.70 379.40
(1.04%)
Nikkei 225
8,496.80 1.95
(0.02%)
Forex
USD-INR
84.76 -0.40
(-0.47%)
EUR-INR
96.29 -0.73
(-0.75%)
GBP-INR
113.24 -0.94
(-0.82%)
JPY-INR
0.59 0.00
(-0.75%)

EQUITY - MARKET SCREENER

Jagsonpal Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
507789
INE048B01035
29.695309
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
JAGSNPHARM
41.02
1495.04
EPS(TTM)
Face Value()
Div & Yield %
5.49
2
0.88
 

bil enterprise ltd
KCD Industries India Ltd - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Friday 14Th February 2025
Feb 14,2025
Dear Sir/Madam This is to notify the exchange that the Board of Directors of the Company at their meeting held today i.e. Friday 14th February 2025 at the Registered Office of the Company considered and approved Un-audited Standalone & Consolidated Financial Results for quarter and nine months ended as on 31st December 2024; Further a copy of the said financial results along with the Limited Review Report issued by the Statutory Auditors thereon is enclosed herewith. The meeting of the Board of Directors commenced at 3.10 P.M. and concluded at 3.40 P.M.